ASPN vs. THC
ASPN (Aspen Aerogels, Inc.) and THC (Tenet Healthcare Corporation) are both stocks. ASPN operates in Building Products & Equipment (Industrials), while THC operates in Medical Care Facilities (Healthcare). Over the past 10 years, ASPN returned -0.71%/yr vs 24.90%/yr for THC. Their 0.21 correlation means their historical movements had little consistent relationship.
Performance
ASPN vs. THC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASPN achieves a 63.60% return, which is significantly higher than THC's 28.21% return. Over the past 10 years, ASPN has underperformed THC with an annualized return of -0.71%, while THC has yielded a comparatively higher 24.90% annualized return.
ASPN
- 1D
- 2.66%
- 1M
- -17.03%
- 6M
- 37.39%
- YTD
- 63.60%
- 1Y
- -39.08%
- 3Y*
- -17.28%
- 5Y*
- -34.24%
- 10Y*
- -0.71%
- ALL TIME*
- -6.88%
THC
- 1D
- 0.81%
- 1M
- 25.06%
- 6M
- 34.60%
- YTD
- 28.21%
- 1Y
- 61.16%
- 3Y*
- 49.16%
- 5Y*
- 28.81%
- 10Y*
- 24.90%
- ALL TIME*
- 6.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $4.81M | $4.87M | $8.20M | |
| $388.53M | $322.77M | $279.36M |
ASPN vs. THC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASPN Aspen Aerogels, Inc. | 63.60% | -76.18% | -24.71% | 33.84% | -76.32% | 198.32% | 115.08% | 264.32% | -56.35% | 18.16% |
THC Tenet Healthcare Corporation | 28.21% | 57.43% | 67.04% | 54.89% | -40.27% | 104.58% | 5.00% | 121.88% | 13.06% | 2.16% |
Correlation
The correlation between ASPN and THC is -0.00, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.00 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jun 13, 2014 | 0.21 |
The correlation between ASPN and THC shifts across timeframes, from -0.00 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ASPN:
$383.72M
THC:
$20.51B
ASPN:
-$1.36
THC:
$19.34
ASPN:
1.66
THC:
1.05
ASPN:
$230.26M
THC:
$21.46B
ASPN:
$27.46M
THC:
$9.18B
ASPN:
-$59.70M
THC:
$4.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASPN vs. THC — Risk / Return Rank
ASPN
THC
ASPN vs. THC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aspen Aerogels, Inc. (ASPN) and Tenet Healthcare Corporation (THC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASPN | THC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.77 | ||
| Sortino ratioReturn per unit of downside risk | -2.35 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.27 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.56 | 1.71 | -2.27 |
| Martin ratioReturn relative to average drawdown | -0.83 | 3.90 | -4.73 |
Loading charts...
Drawdowns
ASPN vs. THC - Drawdown Comparison
The maximum ASPN drawdown since its inception was -95.96%, roughly equal to the maximum THC drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for ASPN and THC.
Loading charts...
Drawdown Indicators
| ASPN | THC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.96% | -98.28% | +2.32% |
Max Drawdown (1Y)Largest decline over 1 year | -70.86% | -34.08% | -36.78% |
Max Drawdown (3Y)Largest decline over 3 years | -91.90% | -34.48% | -57.42% |
Max Drawdown (5Y)Largest decline over 5 years | -95.96% | -58.88% | -37.08% |
Max Drawdown (10Y)Largest decline over 10 years | -95.96% | -71.68% | -24.28% |
Current DrawdownCurrent decline from peak | -92.73% | -2.99% | -89.74% |
Average DrawdownAverage peak-to-trough decline | -56.82% | -51.45% | -5.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.63% | 14.90% | +32.73% |
Volatility
ASPN vs. THC - Volatility Comparison
Aspen Aerogels, Inc. (ASPN) and Tenet Healthcare Corporation (THC) have volatilities of 21.62% and 21.56%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASPN | THC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.62% | 21.56% | +0.06% |
Volatility (6M)Calculated over the trailing 6-month period | 68.21% | 35.55% | +32.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.48% | 43.24% | +50.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.38% | 45.22% | +42.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.19% | 56.63% | +18.56% |
Dividends
ASPN vs. THC - Dividend Comparison
Neither ASPN nor THC has paid dividends to shareholders.
Financials
ASPN vs. THC - Financials Comparison
This section allows you to compare key financial metrics between Aspen Aerogels, Inc. and Tenet Healthcare Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ASPN vs. THC - Profitability Comparison
ASPN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Aspen Aerogels, Inc. reported a gross profit of 4.28M and revenue of 37.88M. Therefore, the gross margin over that period was 11.3%.
THC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Tenet Healthcare Corporation reported a gross profit of 882.00M and revenue of 5.37B. Therefore, the gross margin over that period was 16.4%.
ASPN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Aspen Aerogels, Inc. reported an operating income of -20.83M and revenue of 37.88M, resulting in an operating margin of -55.0%.
THC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Tenet Healthcare Corporation reported an operating income of 882.00M and revenue of 5.37B, resulting in an operating margin of 16.4%.
ASPN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Aspen Aerogels, Inc. reported a net income of -23.69M and revenue of 37.88M, resulting in a net margin of -62.5%.
THC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Tenet Healthcare Corporation reported a net income of 702.00M and revenue of 5.37B, resulting in a net margin of 13.1%.
Frequently Asked Questions
ASPN and THC have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASPN has higher volatility (21.62%) compared to THC (21.56%). In terms of maximum drawdown, ASPN dropped -95.96% vs THC's -98.28%.
THC currently has the higher Sharpe Ratio (1.35 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASPN and THC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer